David Y. Mitchell, Ph.D. Named Nuventra Pharma Sciences’ Chief Scientific Officer

DURHAM, N.C.--(BUSINESS WIRE)--Nuventra is pleased to announce that David Y. Mitchell, Ph.D. will serve as the company’s new Chief Scientific Officer (CSO). Dr. Mitchell, who has 25 years of pharmaceutical and biotechnology experience in clinical pharmacology, project leadership, and strategic drug development, will be anchoring Nuventra’s newest office located in the Greater Denver Area and focusing on pharmacokinetic, pharmacodynamic, and pharmacometric services for our clients.

Help employers find you! Check out all the jobs and post your resume.